The natives are getting restless.
Maybe I see things a bit differently than you do. If the plan is to partner up for AVXL, we want max value in that partnership. It takes time to create a product that has achieved max value. The more evidence we can gather that supports efficacy, the more we can integrate precision medicine techniques to identify the best patient candidates, the more we can use technology to help market the product --- all of this is long-term accretive to maximizing the value of the company.
I know a family that started a business many years ago in the local mall. 20 years later they sold it for $250 million or something. Today, the company is worth north of $30 billion. They sold partially because the CEO wanted to retire, but also because the impatient investors wanted their money ASAP. In 5 more years, this company is projected to be worth north of $100B. Do you think the VC's who demanded a sale at $250M regret their decision not to wait another 5-10 years? I do.
I am glad that Dr. Missling is taking his time and making the right moves to ensure that when we do enter partnership discussions, we are doing so from the position of greatest strength possible. If that takes a bit more time, so be it. I've got plenty of other stocks and investments to occupy my time until then.
Market Data 
Markets 
AI
